PART I . Overview We are a commercial-stage company with a late-stage pipeline committed to redefining what is possible in bringing life-changing therapies to people living with rare diseases. We are focused on expanding patient access, progressing our pipeline toward key milestones, and delivering meaningful therapeutics. Our vision is realized through disciplined execution of our strategic plan and our core values patient centricity, integrity, accountability, innovation, and courage which gui...
Q2 FY2026 — expected 2026-08-10
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-09 | 2025-12-31 | 0001434647-26-000011 | EDGAR | 71K words |
| 2025-03-12 | 2024-12-31 | 0001437749-25-007320 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001437749-24-010430 | EDGAR | — |
| 2023-03-07 | 2022-12-31 | 0001437749-23-005703 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001437749-22-007725 | EDGAR | — |
| 2021-03-12 | 2020-12-31 | 0001437749-21-005785 | EDGAR | — |
| 2020-02-28 | 2019-12-31 | 0001437749-20-003965 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001437749-19-003789 | EDGAR | — |
| 2018-03-30 | 2017-12-31 | 0001437749-18-005932 | EDGAR | — |
| 2017-03-10 | 2016-12-31 | 0001437749-17-004317 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001434647-26-000068 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001434647-25-000011 | EDGAR | 32K words |
| 2025-08-12 | 2025-06-30 | 0001628280-25-039967 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0001437749-25-016523 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0001437749-24-034916 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001437749-24-026474 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0001437749-24-015705 | EDGAR | — |
| 2023-11-07 | 2023-09-30 | 0001437749-23-030690 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001437749-23-023716 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001437749-23-014683 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001437749-22-026683 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001437749-22-020394 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001434647-26-000067 | EDGAR | — |
| 2026-03-16 | 0001434647-26-000015 | EDGAR | 1K words |
| 2026-03-09 | 0001434647-26-000009 | EDGAR | — |
| 2025-12-17 | 0001434647-25-000018 | EDGAR | — |
| 2025-12-02 | 0001434647-25-000015 | EDGAR | — |
| 2025-11-20 | 0001193125-25-289865 | EDGAR | — |
| 2025-11-05 | 0001434647-25-000009 | EDGAR | — |
| 2025-08-12 | 0001628280-25-039883 | EDGAR | — |
| 2025-05-29 | 0001193125-25-130714 | EDGAR | — |
| 2025-05-13 | 0001437749-25-016452 | EDGAR | — |
297 total filings indexed. 265 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001434647 |
| Ticker | ZVRA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.zevra.com |
| Listed | 2015-04-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ZVRA (~200 tokens, structured JSON with cryptographic provenance)